SCHEMBL9199503

SCHEMBL9199503

CCN(CCO)CP(=O)(O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.41
CYP1A2 P05177 2/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
HIF1A Q16665 1/20 0.41
HSD17B10 Q99714 1/20 0.41
FDPS P14324 3/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 1/20 0.38
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP8 P22894 1/20 0.33
CYP2D6 P10635 1/20 0.32
PPARD Q03181 1/20 0.31
ARG1 P05089 1/20 0.31
ARG2 P78540 1/20 0.31
MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25908106 0.96 CYP2C9 (0.42) CYP2C9CYP1A2HPGDMAPK1HIF1A
SCHEMBL26875632 0.88 FDPS (0.42) CYP2C9MAPK1HSD17B10FDPSMEN1
SCHEMBL1420967 0.85 KDM4E (0.34) MAPK1HSD17B10FDPSMMP2MAPT
SCHEMBL1954630 0.85 KDM4E (0.34) MAPK1HSD17B10FDPSMEN1KMT2A
SCHEMBL10021887 0.84 FDPS (0.39) CYP2C9FDPSMEN1GAACYP2C19
SCHEMBL27390569 0.84 FDPS (0.39) CYP2C9FDPSMEN1GAACYP2C19
Water SCHEMBL9196726 0.83 KDM4E (0.33) MAPK1HSD17B10FDPSMMP2MAPT
Water SCHEMBL9196996 0.83 KDM4E (0.33) MAPK1HSD17B10FDPSMMP2MAPT
SCHEMBL6897447 0.83 KDM4E (0.33) MAPK1HSD17B10FDPSMMP2MAPT
Phosphoric Acid SCHEMBL8567167 0.83 CYP1A2 (0.50) CYP2C9CYP1A2HPGDMAPK1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312412-A1 LIMESTONE CALCINED CLAY CEMENT (LC3) CONSTRUCTION COMPOSITION CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2023-10-05 US disclosed
US-20230312413-A1 CONSTRUCTION COMPOSITION CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2023-10-05 US disclosed
US-20230303446-A1 CEMENT-REDUCED CONSTRUCTION COMPOSITION CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2023-09-28 US disclosed
US-20170347644-A1 QUATERNARY DISINFECTANT COMPOSITION WITH ANIONIC SCALE INHIBITING AGENT ECOLAB USA INC. 2017-12-07 US disclosed
EP-0474955-B1 Process for the preparation of N-phosphonomethylglycine by means of an oxidation/dealkylation process MONSANTO CO (US) 1995-07-19 EP disclosed
EP-0474955-A1 Process for the preparation of N-phosphonomethylglycine by means of an oxidation/dealkylation process MONSANTO COMPANY (US) 1992-03-18 EP disclosed
US-4965403-A ALKALI METAL SALTS OF N-PHOSPHONOMETHYLGLYCINE MONSANTO COMPANY (US) 1990-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170347644-A1 QUATERNARY DISINFECTANT COMPOSITION WITH ANIONIC SCALE INHIBITING AGENT TRIM25, TET2, DCTN1 CYP2C9 4303/4885CYP1A2 4284/4885HPGD 4185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.